High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells

Biochemical and Biophysical Research Communications

Volumn 438, Issue 3, 2013, Pages 568-574

  Huang, Wei ^a,b   Xu, Ling ^a   Zhou, Xueqin ^a,c   Gao, Chenlin ^a   Yang, Maojun ^a   Chen, Guo ^a   Zhu, Jianhua ^a   Jiang, Lan ^a   Gan, Huakui ^d   Gou, Fang ^a   Feng, Hong ^a   Peng, Juan ^a   Xu, Yong ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b Xindu   (China)

^c People's Hospital of Leshan   (China)

^d Department of Endocrinology   (China)

Author keywords

Diabetic nephropathy; Inflammation; Nuclear factor B; Sumoylation

Indexed keywords

GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FIBROSIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INFLAMMATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION; WESTERN BLOTTING;

DIABETIC NEPHROPATHY; INFLAMMATION; NUCLEAR FACTOR ΚB; SUMOYLATION;

ANIMALS; CHEMOKINE CCL2; DIABETIC NEPHROPATHIES; GLUCOSE; I-KAPPA B PROTEINS; MESANGIAL CELLS; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION FACTOR RELA;

RATTUS;

EID: 84882809843     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.065     Document Type: Article

References (27)

1. Deepa B., Venkatraman Anuradha C. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats. Toxicol. Mech. 2013, 23:223-234.
2. Siednienko J., Gorczyca W.A. Regulation of NF-kappa B activity. Postepy Hig. Med. Dosw. 2003, 57:19-32.
3. Schröfelbauer B., Polley S., Behar M., Ghosh G., Hoffmann A. NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα. Mol. Cell 2012, 47:111-121.
4. McCool K.W., Miyamoto S. DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol. Rev. 2012, 246:311-326.
5. Ren Z., Cui J., Huo Z., Xue J., Cui H., Luo B., Jiang L., Yang R. Cordycepin suppresses TNF-α-induced NF-κB activation by reducing p65 transcriptional activity, inhibiting IκBα phosphorylation, and blocking IKKγ ubiquitination. Int. Immunopharmacol. 2012, 14:698-703.
6. Walsh G. Post-translational modifications of protein biopharmaceuticals. Drug Discov. Today 2010, 15:773-780.
7. Chung H.S., Wang S.B., Venkatraman V., Murray C.I., Van Eyk J.E. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ. Res. 2013, 112:382-392.
8. Bhowmick P., Pancsa R., Guharoy M., Tompa P. Functional diversity and structural disorder in the human ubiquitination pathway. PLoS One 2013, 8:e65443.
9. Cubeñas-Potts C. Matunis MJ, SUMO: a multifaceted modifier of chromatin structure and function. Dev. Cell 2013, 24:1-12.
10. Castro P.H., Tavares R.M., Bejarano E.R., Azevedo H. SUMO, a heavyweight player in plant abiotic stress responses. Cell. Mol. Life Sci. 2012, 69:3269-3283.
11. Hickey C.M., Wilson N.R., Hochstrasser M. Function and regulation of SUMO proteases. Nat. Rev. 2012, 13:755-766.
12. Manning Fox J.E., Hajmrle C., Macdonald P.E. Novel roles of SUMO in pancreatic β-cells: thinking outside the nucleus. Can. J. Physiol. Pharmacol. 2012, 90:765-770.
13. Liu Y., Bridges R., Wortham A., Kulesz-Martin M. NF-κB repression by PIAS3 mediated RelA SUMOylation. PLoS One 2012, 7:e37636.
14. Journo C., Bonnet A., Favre-Bonvin A., Turpin J., Vinera J., CÔté E., Chevalier S.A., Kfoury Y., Bazarbachi A., Pique C., Mahieux R. Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J. Virol. 2013, 87:1123-1136.
15. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 2005, 11:183-190.
16. Yang W., Sheng H., Homi H.M., Warner D.S., Paschen W. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation - a new target for therapeutic intervention?. J. Neurochem. 2008, 106:989-999.
17. Tempé D., Piechaczyk M., Bossis G. SUMO under stress. Biochem. Soc. Trans. 2008, 36:874-878.
18. Praefcke G.J., Hofmann K., Dohmen R.J. SUMO playing tag with ubiquitin. Trends Biochem. Sci. 2012, 37:23-31.
19. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of I kappaB alpha inhibits NF-kappaB activation. Mol. Cell 1998, 2:233-239.
20. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 2001, 276:12654-12659.
21. Turpin P., Hay R.T., Dargemont C. Characterization of I kappaB alpha nuclear import pathway. J. Biol. Chem. 1999, 274:6804-6812.
22. Aillet F., Lopitz-Otsoa F., Egaña I., Hjerpe R., Fraser P., Hay R.T., Rodriguez M.S. LangV, heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity. PLoS One 2012, 7:e51672.
23. Culver C., Sundqvist A., Mudie S., Melvin A., Xirodimas D., Rocha S. Mechanism of hypoxia-induced NF-kappaB. Mol. Cell. Biol. 2010, 30:4901-4921.
24. Mabb A.M., Miyamoto S. SUMO and NF-kappaB ties. Cell. Mol. Life Sci. 2007, 64:1979-1996.
25. Saitoh H., Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 2000, 275:6252-6258.
26. Aillet F., Lopitz-Otsoa F., Egaña I., Hjerpe R., Fraser P., Hay R.T., Rodriguez M.S., Lang V. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity. PLoS One 2012, 7:e51672.
27. Yang Y., Xia F., Hermance N., Mabb A., Simonson S., Morrissey S., Gandhi P., Munson M., Miyamoto S. Kelliher MA.A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol. Cell. Biol. 2011, 31:2774-2786.